IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288 | -20.2% | 63,289 | +23.4% | 0.00% | 0.0% |
| Q2 2023 | $361 | +61.9% | 51,294 | +40.7% | 0.00% | 0.0% |
| Q1 2023 | $223 | -2.2% | 36,468 | +2.1% | 0.00% | 0.0% |
| Q4 2022 | $228 | -99.9% | 35,722 | -7.4% | 0.00% | -33.3% |
| Q3 2022 | $369,000 | +67.0% | 38,562 | +92.5% | 0.00% | +200.0% |
| Q2 2022 | $221,000 | -48.6% | 20,031 | -22.4% | 0.00% | -50.0% |
| Q1 2022 | $430,000 | -4.7% | 25,809 | +9.2% | 0.00% | 0.0% |
| Q4 2021 | $451,000 | -3.4% | 23,627 | +24.7% | 0.00% | -33.3% |
| Q3 2021 | $467,000 | +26.2% | 18,946 | +33.3% | 0.00% | +50.0% |
| Q2 2021 | $370,000 | -3.1% | 14,211 | +17.9% | 0.00% | 0.0% |
| Q1 2021 | $382,000 | -16.0% | 12,056 | +23.0% | 0.00% | -33.3% |
| Q4 2020 | $455,000 | +126.4% | 9,798 | +60.4% | 0.00% | +200.0% |
| Q3 2020 | $201,000 | +8.6% | 6,110 | -57.8% | 0.00% | 0.0% |
| Q2 2018 | $185,000 | -27.5% | 14,464 | -4.1% | 0.00% | -50.0% |
| Q1 2018 | $255,000 | +65.6% | 15,087 | -21.8% | 0.00% | +100.0% |
| Q4 2017 | $154,000 | – | 19,305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |